Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics (NQ: SRPT )

83.21 USD -1.58 (-1.86%)
Official Closing Price Updated: 7:21 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Sarepta Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
98 99 Next >
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Investor Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 03/08/2021 -- Certain directors of Sarepta Therapeutics, Inc are under investigation concerning potential breaches of fiduciary duties. 
From SBWire - Latest Press Releases
RSI Alert: Sarepta Therapeutics (SRPT) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Sarepta Therapeutics (SRPT) Q4 2020 Earnings Call Transcript
SRPT earnings call for the period ending December 31, 2020. 
Tags Market News SRPT
From Motley Fool
10 Stocks Moving In Monday's After-Hours Session
Gainers Zoom Video Communications (NASDAQ: ZM) shares are trading higher after the company reported better-than-expected Q4 EPS ... 
Tags TVTX Trading Ideas ZM
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 31.41% to $6.61 during Monday's after-market session. Trading volume for ... 
Tags SRPT INVO ARAY
From Benzinga
Recap: Sarepta Therapeutics Q4 Earnings
Shares of Sarepta Therapeutics (NASDAQ:SRPT) decreased in after-market trading after the company reported Q4 results. Quarterly ... 
Tags SRPT Market News Earnings
From Benzinga
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments
From GlobeNewswire News Releases
Earnings Scheduled For March 1, 2021
Companies Reporting Before The Bell • Athenex (NASDAQ:ATNX) is likely to report quarterly loss at $0.44 per share on ... 
Tags GAIA XRAY FGEN
From Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags pharmaceuticals Market News BLUE
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags BOLT BHVN OPTN
From Benzinga
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Earnings Preview: Sarepta Therapeutics
Sarepta Therapeutics (NASDAQ:SRPT) announces its next round of earnings this Monday, March 01. Here is Benzinga's ... 
Tags BZI/EP Benzinga Earnings
From Benzinga
Sarepta Therapeutics Announces FDA Approval of AMONDYS 45™ (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45
From GlobeNewswire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Offerings GBT APLS
From Benzinga
Sarepta Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GTHX RGEN VBLT
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 22 companies set new 52-week lows. Points of Interest: Viatris ... 
Tags BZI/52Weeks MSP IMRA
From Benzinga
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on March 1, 2021
From GlobeNewswire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ALIM ICPT EDIT
From Benzinga
How Will Biden's Executive Orders Affect Your Healthcare Stocks?
The decisions could have both short- and long-term implications. 
Tags QDEL LH SRPT
From Motley Fool
FBT's Underlying Holdings Could Mean 16% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "Company")(NASDAQ: SRPT). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition
From GlobeNewswire News Releases
Repligen Stock Doubled In 2020 — Why Covid Demand Is Fueling It
When it comes to coronavirus vaccines, think of Repligen as the man behind the curtain and RGEN stock as a tools powerhouse. Shares broke out of a cup base in January and hover in a buy zone. 
From Investor's Business Daily
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:... 
From PR Newswire
Sarepta Therapeutics Larger Than S&P 500 Component Kimco Realty
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Sarepta Therapeutics Inc (SRPT) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of ... 
Tags Biotech SRPT Penny Stocks
From Benzinga
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine?
Pfizer sees coronavirus vaccines as a "durable" business, one executive said recently. But don't expect Pfizer stock to be hung up on Covid-19 in 2021. The company sees plenty of catalysts. 
From Investor's Business Daily
Noteworthy Wednesday Option Activity: CALX, CCS, SRPT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Calix Inc (CALX), where a total volume of 4,022 contracts has been traded thus far... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
98 99 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.